NIH-funded research U01 cooperative agreement

A new portable brain scanner for early detection of Alzheimer's disease

Official title: Prism-PET/EMMT: High resolution, cost effective, portable, and upright brain PET scanner for early diagnosis of Alzheimer's disease

Funded at Weill Medical Coll of Cornell Univ · NIH-10947888 · Data updated 2026-11-12

This study is testing a new, easy-to-use brain scanner that helps find early signs of Alzheimer's disease, making it easier for people to get checked even if they don't have symptoms yet.

More s Disease research and trials

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionWeill Medical Coll of Cornell Univ
NIH-funded
Lab location1 site (New York, United States)
Project startSeptember 30, 2024
Project endAugust 31, 2029
Funding year2024
Award (this year)$1,273,935
NIH project number1U01AG082845-01A1
Project IDNIH-10947888 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include adults over 21 years old who are at risk for or showing early signs of Alzheimer's disease.

Less likely to help

Patients with advanced Alzheimer's disease or those who do not exhibit any symptoms of cognitive decline may not benefit from this research.

What this research studies

This research focuses on developing a high-resolution, cost-effective, and portable brain PET scanner designed to improve the early diagnosis of Alzheimer's disease. The innovative Prism-PET scanner, combined with an electromagnetic motion tracker, aims to enhance imaging of critical brain regions affected by tau accumulation. By utilizing a specific PET radiotracer, the study seeks to identify early biomarkers of Alzheimer's in individuals who may not yet show symptoms. This approach aims to increase access to advanced brain imaging, particularly in community settings.

Why it matters

Potential benefit: If successful, this research could lead to earlier and more accurate diagnoses of Alzheimer's disease, allowing for timely interventions.

How similar studies have gone: Other research has shown promise in using advanced imaging techniques for Alzheimer's diagnosis, but this specific approach with the Prism-PET scanner is novel.

Where this research is happening

  • Weill Medical Coll of Cornell Univ
    New York, United States
    Active

Researchers

  • Principal investigator: Goldan, Amirhossein — Weill Medical Coll of Cornell Univ
  • Study coordinator: Goldan, Amirhossein

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.